XML 38 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Assumptions used in Estimation of Fair Value of the Share-based Payment Awards on the Grant Date

 

 

Year Ended

 

 

December 31,

 

 

2020

 

2019

Risk-free interest rate

 

1.6% - 2.5%

 

1.6% - 2.5%

Volatility

 

128% - 138.5%

 

128% - 138.5%

Expected life (years)

 

3.0 - 5.0

 

3.0 - 5.0

Dividend yield

 

0 %

 

0 %

 

Summary of Option and RSU Activity under Amended and Restated 2000 Stock Option and Equity Incentive Plan and Amended and Restated 2010 Equity Incentive Plan

A summary of stock option and restricted stock unit (RSU) award activity under the Plans is presented below (in thousands, except exercise price):

 

 

 

 

 

 

 

Options outstanding

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

Shares

 

 

 

 

 

 

Average

 

 

 

Available

 

 

Number of

 

 

Exercise

 

 

 

for Grant

 

 

Shares

 

 

Prices

 

Balance as of January 1, 2019

 

 

200

 

 

 

17

 

 

$

96.24

 

Additional shares authorized under the Plan

 

 

183

 

 

 

 

 

 

 

RSUs granted

 

 

(120

)

 

 

 

 

 

 

RSUs cancelled and returned to the Plan

 

 

1

 

 

 

 

 

 

 

Options granted

 

 

(145

)

 

 

145

 

 

$

2.64

 

Options cancelled and returned to the Plan

 

 

1

 

 

 

(1

)

 

$

144.00

 

Plan termination

 

 

(32

)

 

 

 

 

$

 

Balance as of December 31, 2019

 

 

88

 

 

 

161

 

 

$

10.85

 

RSUs granted

 

 

(9

)

 

 

 

 

 

 

RSUs cancelled and returned to the Plan

 

 

2

 

 

 

 

 

 

 

Options cancelled

 

 

 

 

 

(2

)

 

$

4.00

 

Balance as of December 31, 2020

 

 

81

 

 

 

159

 

 

$

10.82

 

 

Summary of RSU Activity under the Plans

A summary of RSU activity under the Plans is presented below (in thousands, except fair value):

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

Non-vested shares as of January 1, 2019

 

 

14

 

 

$

24.31

 

Granted

 

 

120

 

 

$

3.79

 

Vested

 

 

(30

)

 

$

12.89

 

Cancelled

 

 

(1

)

 

$

25.13

 

Non-vested shares as of December 31, 2019

 

 

103

 

 

$

3.75

 

Granted

 

 

9

 

 

$

1.74

 

Vested

 

 

(43

)

 

$

3.72

 

Cancelled

 

 

(4

)

 

$

4.00

 

Non-vested shares as of December 31, 2020

 

 

65

 

 

$

3.48

 

Summary of Significant Ranges of Outstanding and Exercisable Options

The following table summarizes significant ranges of outstanding and exercisable options at December 31, 2020 (in thousands, except contractual life and exercise price):

 

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Weighted

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Contractual

 

 

Average

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Life

 

 

Exercise

 

 

Number

 

 

Exercise

 

 

Intrinsic

 

Range of Exercise Price

 

Outstanding

 

 

(in Years)

 

 

Price

 

 

Exercisable

 

 

Price

 

 

value

 

$1.57 - $14.99

 

 

143

 

 

 

8.26

 

 

$

2.62

 

 

 

68

 

 

$

2.94

 

 

$

25

 

$15.00 - $25.59

 

 

8

 

 

 

2.74

 

 

$

15.00

 

 

 

8

 

 

$

15.00

 

 

$

 

$25.60 - $143.99

 

 

2

 

 

 

3.35

 

 

$

41.81

 

 

 

2

 

 

$

41.81

 

 

$

 

$144.00 - $409.99

 

 

5

 

 

 

5.65

 

 

$

144.00

 

 

 

5

 

 

$

144.00

 

 

$

 

$410.00 - $924.00

 

 

1

 

 

 

4.19

 

 

$

430.64

 

 

 

1

 

 

$

430.64

 

 

$

 

$1.57 - $924.00

 

 

159

 

 

 

7.80

 

 

$

10.82

 

 

 

84

 

 

$

18.39

 

 

$

25